small sized icon representing the Cardiovascular area of interest
Cardiovascular
GME:X Logo
GME:X
medium sized icon representing the Diabetes Care area of interest
Diabetes Care
small sized icon representing the Radiology area of interest
Radiology
small sized icon representing the Oncology area of interest
Oncology
small sized icon representing the Ophthalmology area of interest
Ophthalmology
small sized icon representing the Women's Health area of interest
Women's Health
medium sized icon representing the Nephrology area of interest
Nephrology
Bayer MedLearnEducate, Innovate & Heal
Podcast

Dr Javed Butler: NT-Pro BNP Interpretation

Dr. Javed Butler delves into the nuances of NT-pro BNP analysis in the Victoria trial, clarifying misconceptions about its impact on heart failure outcomes. Patients with NT-pro BNP below 8,000 showed significant cardiovascular mortality and hospitalization reduction, while those above 8,000 experienced no benefit, indicating progression to advanced heart failure. Dr. Butler highlights the importance of anti-pro BNP data in identifying suitable candidates for vericiguat

Our speakers

  • MD, MPH, MBA, Baylor Scott and White Health.

    Dr. Javed Butler is a prominent figure in cardiovascular medicine, especially known for his work on heart failure. Based in Dallas, Texas, he holds leadership positions at Baylor Scott & White, including the Maxwell A. and Gayle H. Clampitt Endowed Chair, president, and chief research executive at the Research Institute, and senior vice president at the Health system. His expertise is recognized by his fellowships in several prestigious organizations, such as the Heart Failure Society of America, the European Society of Cardiology, the American College of Cardiology, and the American Heart Association.

Related content
Dr Javed Butler: Worsening Heart Failure
PP-VER-IN-0202-1, September 2024
Dr Javed Butler: Vericiguat in Heart Failure
PP-VER-IN-0231-1, September 2024
Dr Javed Butler: Initiating vericiguat
PP-VER-IN-0232-1, September 2024